Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | SSTR1 | P30872 | 3/20 | 0.41 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.41 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.41 |
| ▸ | SSTR3 | P32745 | 3/20 | 0.41 |
| ▸ | SSTR5 | P35346 | 3/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | TACR1 | P25103 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | GJB2 | P29033 | 2/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7564024 | 1.00 | PDE4D (0.51) | PDE4DBCHEACHESSTR1SSTR2 | |
| SCHEMBL7564028 | 1.00 | PDE4D (0.51) | PDE4DBCHEACHESSTR1SSTR2 | |
| SCHEMBL7570826 | 0.83 | PDE4D (0.57) | PDE4DBCHEACHESSTR1SSTR2 | |
| SCHEMBL7570823 | 0.83 | PDE4D (0.57) | PDE4DBCHEACHESSTR1SSTR2 | |
| SCHEMBL7570831 | 0.83 | PDE4D (0.57) | PDE4DBCHEACHESSTR1SSTR2 | |
| SCHEMBL24058165 | 0.82 | PDE4D (0.58) | PDE4DBCHEACHESSTR1SSTR2 | |
| SCHEMBL20010819 | 0.82 | PDE4D (0.52) | PDE4DBCHEACHESSTR1SSTR2 | |
| SCHEMBL8933680 | 0.82 | PDE4D (0.52) | PDE4DBCHEACHESSTR1SSTR2 | |
| SCHEMBL31556052 | 0.82 | PDE4D (0.58) | PDE4DBCHEACHESSTR1SSTR2 | |
| SCHEMBL20172482 | 0.81 | PDE4D (0.51) | PDE4DBCHEACHESSTR1SSTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12410208-B2 | (2-acetamidyl)thio-beta-D-galactopyranoside derivatives | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-09-09 | — | — | US | disclosed |
| EP-0830365-B1 | MODIFIED KOJIBIOSIDES ANALOGUES | ALBERTA RES COUNCIL (CA) | 2002-09-04 | — | — | EP | disclosed |
| EP-0837867-B1 | MODIFIED ALPHA-D-Glcp-(1-2)-ALPHA-D-Glcp-(1-3)-ALPHA-D-Glcp-ANALOGUES | ALBERTA RES COUNCIL (CA) | 2001-08-16 | — | — | EP | disclosed |
| US-5929037-A | GLUCOSIDASE I INHIBITORS | ALBERTA RESEARCH COUNCIL (CA) | 1999-07-27 | — | — | US | disclosed |
| US-5877157-A | Modified kojibioside analogues | ALBERTA RESEARCH COUNCIL (CA) | 1999-03-02 | — | — | US | disclosed |
| EP-0837867-A1 | MODIFIED $g(a)-D-Glcp-(1-2)-$g(a)-D-Glcp-(1-3)-$g(a)-D-Glcp-ANALOGUES | ALBERTA RESEARCH COUNCIL (CA) | 1998-04-29 | — | — | EP | disclosed |
| EP-0830365-A1 | MODIFIED KOJIBIOSIDES ANALOGUES | ALBERTA RESEARCH COUNCIL (CA) | 1998-03-25 | — | — | EP | disclosed |
| US-5633233-A | Modified kojibiosides analogues | ALBERTA RESEARCH COUNCIL (CA) | 1997-05-27 | — | — | US | disclosed |
| WO-1996040700-A1 | MODIFIED α-D-Glcp-(1-2)-α-D-Glcp-(1-3)-α-D-Glcp-ANALOGUES | ALBERTA RESEARCH COUNCIL (CA) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040702-A1 | MODIFIED KOJIBIOSIDES ANALOGUES | ALBERTA RESEARCH COUNCIL (CA) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410208-B2 | (2-acetamidyl)thio-beta-D-galactopyranoside derivatives | LGALS1, LGALS3, LGALS2 | PDE4D 1552/4885BCHE 4282/4885ACHE 1895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.